Shanghai Yizhong Pharmaceutical Co., Ltd. (SHA:688091)
51.46
+2.58 (5.28%)
Feb 3, 2026, 3:00 PM CST
SHA:688091 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 68.14 | 649.53 | 914.76 | 710.38 | 110.43 | 0.19 |
Short-Term Investments | 10.32 | 21.7 | - | 78.46 | 10.05 | 10 |
Trading Asset Securities | 406.93 | - | 325.42 | 338.9 | 832.65 | 40.66 |
Cash & Short-Term Investments | 485.4 | 671.23 | 1,240 | 1,128 | 953.13 | 50.85 |
Cash Growth | -25.80% | -45.88% | 9.97% | 18.32% | 1774.41% | -61.05% |
Accounts Receivable | 116.96 | 49.27 | 143.15 | 42.44 | 4.1 | - |
Other Receivables | 10.2 | 0.08 | - | - | 9.35 | 4.92 |
Receivables | 127.16 | 49.35 | 143.15 | 42.44 | 13.46 | 4.92 |
Inventory | 66.03 | 45.17 | 28.41 | 17.06 | 11.78 | 1.48 |
Prepaid Expenses | 7.7 | 2.71 | 0.53 | 1.76 | 3.36 | - |
Other Current Assets | 4.28 | 7.75 | 0.98 | 10.71 | 11.82 | 0.48 |
Total Current Assets | 690.56 | 776.21 | 1,413 | 1,200 | 993.55 | 57.73 |
Property, Plant & Equipment | 261.41 | 149.28 | 120.21 | 121.45 | 83.95 | 87.82 |
Long-Term Investments | - | 467.77 | 21.01 | 20.32 | 105.82 | 103.48 |
Other Intangible Assets | 28.85 | 8.36 | 8.58 | 8.79 | 9.01 | 9.23 |
Long-Term Deferred Tax Assets | 8.87 | 7.62 | 5.65 | 1.84 | 6.07 | - |
Long-Term Deferred Charges | 7.36 | 8.59 | 1.86 | 0.22 | - | 0.56 |
Other Long-Term Assets | 546.62 | 30.16 | 2.81 | 2.25 | 2.16 | - |
Total Assets | 1,544 | 1,448 | 1,573 | 1,355 | 1,201 | 258.81 |
Accounts Payable | 53.62 | 24.7 | 31.83 | 13.58 | 0.74 | 1.82 |
Accrued Expenses | 16.93 | 5.52 | 7.56 | 6.08 | 1.62 | 3.67 |
Short-Term Debt | - | - | 44.03 | - | 16.75 | 3.25 |
Current Income Taxes Payable | 3.88 | - | 10.3 | - | - | - |
Current Unearned Revenue | 1.72 | 4.38 | 1.11 | 0.12 | - | - |
Other Current Liabilities | 3.49 | 4.84 | 9.16 | 10.08 | 2 | 2.77 |
Total Current Liabilities | 79.64 | 39.45 | 103.98 | 29.86 | 21.1 | 11.51 |
Long-Term Unearned Revenue | 0.71 | 1.03 | 1.47 | 2.29 | 3.13 | 3.79 |
Long-Term Deferred Tax Liabilities | 2.41 | 2.5 | 3.07 | 3.26 | 0.79 | - |
Total Liabilities | 82.76 | 42.97 | 108.52 | 35.42 | 25.02 | 15.3 |
Common Stock | 206.7 | 206.59 | 158.28 | 143.89 | 105.8 | 79.35 |
Additional Paid-In Capital | 1,048 | 1,043 | 1,072 | 1,059 | 1,096 | 186.72 |
Retained Earnings | 243.25 | 192.59 | 234.68 | 116.29 | -26.56 | -22.56 |
Treasury Stock | -37.24 | -37.24 | - | - | - | - |
Shareholders' Equity | 1,461 | 1,405 | 1,465 | 1,319 | 1,176 | 243.51 |
Total Liabilities & Equity | 1,544 | 1,448 | 1,573 | 1,355 | 1,201 | 258.81 |
Total Debt | - | - | 44.03 | - | 16.75 | 3.25 |
Net Cash (Debt) | 485.4 | 671.23 | 1,196 | 1,128 | 936.38 | 47.6 |
Net Cash Growth | -24.54% | -43.88% | 6.07% | 20.44% | 1867.20% | -63.53% |
Net Cash Per Share | 2.10 | 2.89 | 7.55 | 5.47 | 6.02 | 0.31 |
Filing Date Shares Outstanding | 205.43 | 205.31 | 205.76 | 205.76 | 205.76 | 154.32 |
Total Common Shares Outstanding | 205.43 | 205.31 | 205.76 | 205.76 | 205.76 | 154.32 |
Working Capital | 610.92 | 736.76 | 1,309 | 1,170 | 972.45 | 46.22 |
Book Value Per Share | 7.11 | 6.84 | 7.12 | 6.41 | 5.71 | 1.58 |
Tangible Book Value | 1,432 | 1,397 | 1,456 | 1,310 | 1,167 | 234.28 |
Tangible Book Value Per Share | 6.97 | 6.80 | 7.08 | 6.37 | 5.67 | 1.52 |
Buildings | - | 80.55 | 80.55 | 80.55 | 80.55 | 80.55 |
Machinery | - | 81.55 | 76.29 | 35.23 | 29.38 | 27.87 |
Construction In Progress | - | 39.49 | 4.81 | 39.44 | 1.58 | 0.57 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.